Comment on “Predictors of short-term outcomes related to central subfield foveal thickness after intravitreal bevacizumab for macular edema due to central retinal vein occlusion”

Ítems similars

• Comment on “Predictors of short-term outcomes related to central subfield foveal thickness after intravitreal bevacizumab for macular edema due to central retinal vein occlusion”
  per: Dan Călugăru, et al.
  Publicat: (2017-09-01)
• Predictors of short-term outcomes related to central subfield foveal thickness after intravitreal bevacizumab for macular edema due to central retinal vein occlusion
  per: Wang, Mei-Zi, et al.
  Publicat: (2016)
• Comment on “Correlation between macular ganglion cell-inner plexiform layer thickness and visual acuity after resolution of the macular edema secondary to central retinal vein occlusion”
  per: Călugăru, Dan, et al.
  Publicat: (2019)
• Comment on “Intravitreal dexamethasone implants for diabetic macular edema”
  per: Călugăru, Dan, et al.
  Publicat: (2018)
• Comment on: ‘Intravitreal aflibercept for macular oedema secondary to central retinal vein occlusion in patients with prior treatment with bevacizumab or ranibizumab'
  per: Călugăru, D, et al.
  Publicat: (2016)